| 1 |
Michael T. Rudd |
Merck |
6 |
| 1 |
Raymond L. Sharrah |
Streamlight |
6 |
| 3 |
Robert A. Johnson |
Unisys |
5 |
| #4 |
Bryan Wayne King |
Glaxosmithkline Intellectual Property Development Limited |
4 |
| #4 |
Jae U. Jeong |
Glaxosmithkline Intellectual Property Development Limited |
4 |
| #6 |
Clark A. Sehon |
Glaxosmithkline Intellectual Property Development Limited |
3 |
| #6 |
Jianxing Kang |
Glaxosmithkline Intellectual Property Development Limited |
3 |
| #6 |
Philip Anthony Harris |
Smithkline Beecham Limited |
3 |
| #6 |
William A. McHale |
Premier Dental Products |
3 |
| #6 |
Daniel Davenport |
Globus Medical |
3 |
| #6 |
Patrick Murray |
Globus Medical |
3 |
| #6 |
Jeffrey S. Lueth |
Globus Medical |
3 |
| #6 |
Thomas D. Boris |
Streamlight |
3 |
| #6 |
Joshi M. Ramanjulu |
Glaxosmithkline Intellectual Property Development Limited |
3 |
| #6 |
Patrick M. Eidam |
Glaxosmithkline Intellectual Property Development Limited |
3 |
| #16 |
Mark A. Destefano |
Amgen |
2 |
| #16 |
Jon M. Wigginton |
Bristol-Myers Squibb |
2 |
| #16 |
Edward J. McShane, III |
Institute For Musculoskeletal Science And Education |
2 |
| #16 |
Milan George |
Globus Medical |
2 |
| #16 |
Qian Gou |
Dow Global Technologies |
2 |
| #16 |
Jonathan C. Barth |
Juniper Networks |
2 |
| #16 |
Stephen A. Koch |
Certainteed |
2 |
| #16 |
Ami Lakdawala Shah |
— |
2 |
| #16 |
Mark D. Westmeyer |
Rohm And Haas |
2 |
| #16 |
Brendan M. Crowley |
Merck |
2 |
| #16 |
Danielle Lange |
Pricewaterhousecoopers Llp |
2 |
| #16 |
Derrick Bingaman |
Globus Medical |
2 |
| #16 |
Eugene L. Stewart |
Glaxosmithkline |
2 |
| #16 |
Robert R. Singhaus, Jr. |
Glaxosmithkline Intellectual Property Development Limited |
2 |
| #16 |
Attiq Rahman |
Glaxosmithkline Intellectual Property Development Limited |
2 |
| #16 |
Daohua Zhang |
Glaxosmithkline Intellectual Property Development Limited |
2 |
| #16 |
Steven William Butcher |
Rb Distribution |
2 |
| #16 |
Lara Kathryn Leister |
Glaxosmithkline Intellectual Property Development Limited |
2 |
| #34 |
Gary S. Smith |
Arkema |
1 |
| #34 |
John Hayes |
Rohm And Haas |
1 |
| #34 |
Robert E. Lee TROUT |
Venatorx Pharmaceuticals |
1 |
| #34 |
Janet Drobits Windisch |
Conopeo |
1 |
| #34 |
Christopher W. Morgan |
Glaxosmithkline Intellectual Property (No. 4) Limited |
1 |
| #34 |
Gregory L. Adams |
Glaxosmithkline |
1 |
| #34 |
Michael NAPIER |
— |
1 |
| #34 |
Jacob Rubin |
Glaxosmithkline Intellectual Property Development Limited |
1 |
| #34 |
Shane W. Obrien |
Glaxosmithkline Intellectual Property Development Limited |
1 |
| #34 |
Ngocdiep T. Le |
Novartis Ag |
1 |
| #34 |
Alexander Joseph Reif |
Merck |
1 |
| #34 |
Adam Kenneth Charnley |
Glaxosmithkline Intellectual Property Development Limited |
1 |
| #34 |
Paul A. Benensky |
Certainteed |
1 |
| #34 |
Brent M. Dorr |
Codexis |
1 |
| #34 |
David T. FOSBENNER |
Glaxosmithkline Intellectual Property Development Limited |
1 |
| #34 |
Igor Tentler |
Teleflex Medical Incorporated |
1 |
| #34 |
Manish Mundra |
Dow Global Technologies |
1 |